Antitumor activity ofZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiatesthe effects of radiation in a human non-small cell lung cancer xenograft model. / Raben D; Bianco C; Damiano V; Bianco R; Melisi D; Mignogna C; D'Armiento FP; Cionini L; Bianco AR; Tortora G; Ciardiello F; Bunn P. - In: MOLECULAR CANCER THERAPEUTICS. - ISSN 1535-7163. - (2004).
Titolo: | Antitumor activity ofZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiatesthe effects of radiation in a human non-small cell lung cancer xenograft model. |
Autori: | |
Data di pubblicazione: | 2004 |
Rivista: | |
Handle: | http://hdl.handle.net/11591/189623 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.